Combination of Kiadis’ CD38 knock out K-NK cells with Sanofi’s anti-CD38 antibody Sarclisa® enables optimal tumor cell killing, and offers a potential first-in-class treatment for patients with multiple myelo [...]
Original article was published by Forbes on July 1, 2020.
https://www.forbes.com/sites/johncumbers/2020/07/01/a-new-20-minute-covid-19-test-will-use-crispr-gene-editing-technology-to-deliver-results-at-the- [...]
Eindhoven, NL; July 2, 2020 – GTX Medical (‘GTX’) announced today the appointment of Dave Marver as Chief Executive Officer. Mr. Marver is a highly experienced medtech leader. He will guide GTX through the devel [...]
Amsterdam, the Netherlands, 23 June 2020 - LSP, one of Europe’s leading life sciences and healthcare investors, today announced its investment in OneProjects Ltd, an Irish-German medical device start-up specialising [...]
...to accelerate multiple mRNA therapeutic development programs through to clinical proof of concept
Advancing oncology and infectious diseases pipeline, including new SARS-CoV-2 program
Propriet [...]
Though academic institutions have contributed enormously to the remarkable growth in the healthcare industry, a key limiting resource for this continued growth is the creation of career opportunities for doctoral grad [...]
Eindhoven, NL and Lausanne, CH: June 9, 2020 - GTX medical (GTX), today announced that the US Food and Drug Administration (FDA) has granted Breakthrough Device Designation for its implantable Go-2 system which was de [...]
May 29, 2020 - Breda, the Netherlands / Ghent, Belgium - argenx (Euronext & Nasdaq: ARGX), a clinical-stage biotechnology company developing a deep pipeline of differentiated antibody-based therapies for the t [...]
Orphazyme’s arimoclomol receives US Fast Track Designation in Amyotrophic Lateral Sclerosis
Copenhagen, Denmark, May 22, 2020 – Orphazyme A/S (ORPHA.CO), a biopharmaceutical company pioneering Heat-Shoc [...]
Combination of Kiadis’ CD38 knock out K-NK cells with Sanofi’s anti-CD38 antibody Sarclisa® enables optimal tumor cell killing, and offers a potential first-in-class treatment for patients with multiple myelo [...]
Original article was published by Forbes on July 1, 2020.
https://www.forbes.com/sites/johncumbers/2020/07/01/a-new-20-minute-covid-19-test-will-use-crispr-gene-editing-technology-to-deliver-results-at-the- [...]
Eindhoven, NL; July 2, 2020 – GTX Medical (‘GTX’) announced today the appointment of Dave Marver as Chief Executive Officer. Mr. Marver is a highly experienced medtech leader. He will guide GTX through the devel [...]
Amsterdam, the Netherlands, 23 June 2020 - LSP, one of Europe’s leading life sciences and healthcare investors, today announced its investment in OneProjects Ltd, an Irish-German medical device start-up specialising [...]
...to accelerate multiple mRNA therapeutic development programs through to clinical proof of concept
Advancing oncology and infectious diseases pipeline, including new SARS-CoV-2 program
Propriet [...]
Though academic institutions have contributed enormously to the remarkable growth in the healthcare industry, a key limiting resource for this continued growth is the creation of career opportunities for doctoral grad [...]
Eindhoven, NL and Lausanne, CH: June 9, 2020 - GTX medical (GTX), today announced that the US Food and Drug Administration (FDA) has granted Breakthrough Device Designation for its implantable Go-2 system which was de [...]
May 29, 2020 - Breda, the Netherlands / Ghent, Belgium - argenx (Euronext & Nasdaq: ARGX), a clinical-stage biotechnology company developing a deep pipeline of differentiated antibody-based therapies for the t [...]
Orphazyme’s arimoclomol receives US Fast Track Designation in Amyotrophic Lateral Sclerosis
Copenhagen, Denmark, May 22, 2020 – Orphazyme A/S (ORPHA.CO), a biopharmaceutical company pioneering Heat-Shoc [...]
Follow us
